Viktor Chirikov

653 total citations
59 papers, 482 citations indexed

About

Viktor Chirikov is a scholar working on Epidemiology, Oncology and Economics and Econometrics. According to data from OpenAlex, Viktor Chirikov has authored 59 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 15 papers in Oncology and 13 papers in Economics and Econometrics. Recurrent topics in Viktor Chirikov's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis C virus research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Viktor Chirikov is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatitis C virus research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Viktor Chirikov collaborates with scholars based in United States, United Kingdom and Japan. Viktor Chirikov's co-authors include Fadia T. Shaya, C. Daniel Mullins, Marc Botteman, Brian Seal, Eric A. F. Simões, Nader Hanna, Young‐Min Kwon, Andreas Kuznik, Søren Snitker and Charles D. Howell and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Viktor Chirikov

49 papers receiving 469 citations

Peers

Viktor Chirikov
Hayley Bennett United Kingdom
Nicole Engel-Nitz United States
Steven E. Marx United States
Elizabeth S. Aby United States
Margaret Teng Singapore
Annette Conrads‐Frank United States
A. Burak Ozbay United States
Marko Yurkovich Canada
Noel Santini United States
D. Clements United Kingdom
Hayley Bennett United Kingdom
Viktor Chirikov
Citations per year, relative to Viktor Chirikov Viktor Chirikov (= 1×) peers Hayley Bennett

Countries citing papers authored by Viktor Chirikov

Since Specialization
Citations

This map shows the geographic impact of Viktor Chirikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Chirikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Chirikov more than expected).

Fields of papers citing papers by Viktor Chirikov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Chirikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Chirikov. The network helps show where Viktor Chirikov may publish in the future.

Co-authorship network of co-authors of Viktor Chirikov

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Chirikov. A scholar is included among the top collaborators of Viktor Chirikov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Chirikov. Viktor Chirikov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sibley, Christopher T., et al.. (2025). Economic Burden of Postsurgical Chronic Hypoparathyroidism: A US Medicare Claims Retrospective Analysis. Advances in Therapy. 42(10). 4881–4903. 1 indexed citations
2.
3.
4.
Wilcox, Mark H., Aruni Mulgirigama, Ashish V. Joshi, et al.. (2024). Treatment patterns and burden of uncomplicated urinary tract infection in England: a retrospective cohort study. BJGP Open. 9(2). BJGPO.2024.0214–BJGPO.2024.0214.
5.
Armstrong, April W., et al.. (2023). Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Dermatology and Therapy. 13(11). 2589–2603. 12 indexed citations
6.
7.
Salles, Gilles, Christopher P. Fox, Anthony Wang, et al.. (2023). Efficacy of Subcutaneous Epcoritamab Vs Tisa-Cel in R/R LBCL CAR T-Naive and CAR T-Eligible Patients: An Indirect Comparison. Blood. 142(Supplement 1). 1733–1733.
8.
9.
Simões, Eric A. F., Marc Botteman, & Viktor Chirikov. (2023). Epidemiology of Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection in Japanese Children, 2011–2017. The Journal of Infectious Diseases. 229(4). 1112–1122. 2 indexed citations
10.
11.
Chirikov, Viktor, et al.. (2019). Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China. Clinical Drug Investigation. 39(3). 331–340. 15 indexed citations
12.
Chirikov, Viktor, et al.. (2018). A Prediction Model for Length of Stay in the Icu Among Septic Patients: A Machine Learning Approach. Value in Health. 21. S5–S5. 5 indexed citations
13.
Chirikov, Viktor, et al.. (2018). Development of a Comprehensive Dataset of Hepatitis C Patients and Examination of Disease Epidemiology in the United States, 2013–2016. Advances in Therapy. 35(7). 1087–1102. 24 indexed citations
14.
Zagadailov, Erin, Shelby Corman, Michael P. Hagan, et al.. (2016). Real-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory Hodgkin lymphoma post autologous stem-cell transplantation.. Haematologica. 101. 51–51. 5 indexed citations
15.
Chirikov, Viktor, Fadia T. Shaya, E. Onukwugha, et al.. (2015). Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C Patients. Medical Care. 55(12). e104–e112. 17 indexed citations
16.
Chirikov, Viktor, et al.. (2015). Contextual analysis of determinants of late Diagnosis of Hepatitis C Virus infection in medicare patients. Value in Health. 18(3). A248–A248. 1 indexed citations
17.
Chirikov, Viktor, et al.. (2015). Tree-Based Claims Algorithm For Measuring Pre-Treatment Quality Of Care In Medicare Disabled Hepatitis C Patients. Value in Health. 18(3). A20–A20. 4 indexed citations
18.
Shaya, Fadia T., et al.. (2013). The Use Of Transarterial Chemoembolization For Treating Hepatocellular Carcinoma In The Seer-Medicare Population. Value in Health. 16(3). A1–A2. 1 indexed citations
19.
Shaya, Fadia T., et al.. (2013). Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival. Value in Health. 16(5). 760–768. 16 indexed citations
20.
Chirikov, Viktor, et al.. (2013). Multispecialist Care and Mortality in Hepatocellular Carcinoma. American Journal of Clinical Oncology. 38(6). 557–563. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hayley Bennett Breakdown of academic impact, for papers by Nicole Engel-Nitz Breakdown of academic impact, for papers by Steven E. Marx Breakdown of academic impact, for papers by Elizabeth S. Aby Breakdown of academic impact, for papers by Margaret Teng Breakdown of academic impact, for papers by Annette Conrads‐Frank Breakdown of academic impact, for papers by A. Burak Ozbay Breakdown of academic impact, for papers by Marko Yurkovich Breakdown of academic impact, for papers by Noel Santini Breakdown of academic impact, for papers by D. Clements
Rankless by CCL
2026